Advertisement

Pathophysiology and Treatment of Secondary and Tertiary Hyperparathyroidism

  • Ulrich Güller
  • Michael Mayr
Chapter

25.7 Summary

The surgical indications for patients with secondary or tertiary HPTH are not clearly defined. In general patients who develop PTH autonomy and do not respond to medical management will require PTX. It is also critical to screen all patients who are potential renal transplant recipients for secondary HPTH and to treat severe HPTH prior to transplantation. Both subtotal PTX and total cervical PTX with immediate heterotopic parathyroid transplantation are accepted surgical techniques. Cryopreservation is extremely useful and should always be employed during surgery. The intraoperative PTH assay appears to be a useful adjunct in early studies.

Keywords

Parathyroid Gland Secondary Hyperparathyroidism Phosphate Binder Parathyroid Tissue Nephrol Dial Transplant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moe SM, Drueke TB (2003) Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product. Am J Nephrol 23:369–379PubMedCrossRefGoogle Scholar
  2. 2.
    Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drueke TB (1995) Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047–2053PubMedGoogle Scholar
  3. 3.
    Block GA (2000) Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. Clin Nephrol 54:318–324PubMedGoogle Scholar
  4. 4.
    Malluche HH, Mawad H, Monier-Faugere MC (2004) The importance of bone health in end-stage renal disease: out of the frying pan, into the fire? Nephrol Dial Transplant 19(suppl 1):i9–13PubMedCrossRefGoogle Scholar
  5. 5.
    Hruska K (2000) Pathophysiology of renal osteodystrophy. Pediatr Nephrol 14:636–640PubMedCrossRefGoogle Scholar
  6. 6.
    Qi Q, Monier-Faugere MC, Geng Z, Malluche HH (1995) Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26:622–631PubMedGoogle Scholar
  7. 7.
    Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y (1995) Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26:836–844PubMedGoogle Scholar
  8. 8.
    Brancaccio D, Cozzolino M, Gallieni M (2004) Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach. J Am Soc Nephrol 15(suppl 1):S21–S24PubMedCrossRefGoogle Scholar
  9. 9.
    Chou FF, Ho JC, Huang SC, Sheen-Chen SM (2000) A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg 190:65–70PubMedCrossRefGoogle Scholar
  10. 10.
    Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131–2138PubMedGoogle Scholar
  11. 11.
    Marco MP, Craver L, Betriu A, Belart M, Fibla J, Fernandez E (2003) Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population. Kidney Int Suppl 2003:S111–S114CrossRefGoogle Scholar
  12. 12.
    Rostand SG, Drueke TB (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56:383–392PubMedCrossRefGoogle Scholar
  13. 13.
    Tzanno-Martins C, Futata E, Jorgetti V, Duarte AJ (2000) Restoration of impaired T-cell proliferation after parathyroidectomy in hemodialysis patients. Nephron 84:224–227PubMedCrossRefGoogle Scholar
  14. 14.
    Yasunaga C, Nakamoto M, Matsuo K, Nishihara G, Yoshida T, Goya T (1999) Effects of a parathyroidectomy on the immune system and nutritional condition in chronic dialysis patients with secondary hyperparathyroidism. Am J Surg 178:332–336PubMedCrossRefGoogle Scholar
  15. 15.
    National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1–S266CrossRefGoogle Scholar
  16. 16.
    Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084–1093PubMedCrossRefGoogle Scholar
  17. 17.
    Coen G, Ballanti P, Bonucci E, Calabria S, Costantini S, Ferrannini M, Giustini M, Giordano R, Nicolai G, Manni M, Sardella D, Taggi F (2002) Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron 91:103–111PubMedCrossRefGoogle Scholar
  18. 18.
    Gal-Moscovici A, Popovtzer MM (2002) Parathyroid hormone-independent osteoclastic resorptive bone disease: a new variant of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant 17:620–624PubMedCrossRefGoogle Scholar
  19. 19.
    Coco M, Rush H (2000) Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115–1121PubMedGoogle Scholar
  20. 20.
    Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287–293PubMedGoogle Scholar
  21. 21.
    National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S201Google Scholar
  22. 22.
    US Renal Data System (2003) USRDS 2003 Annual Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney DiseasesGoogle Scholar
  23. 23.
    Levin A, Foley RN (2000) Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 36:S24–S30PubMedGoogle Scholar
  24. 24.
    Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218PubMedCrossRefGoogle Scholar
  25. 25.
    Guerin AP, London GM, Marchais SJ, Metivier F (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014–1021PubMedCrossRefGoogle Scholar
  26. 26.
    Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695–701PubMedCrossRefGoogle Scholar
  27. 27.
    Salgueira M, del Toro N, Moreno-Alba R, Jimenez E, Areste N, Palma A (2003) Vascular calcification in the uremic patient: a cardiovascular risk? Kidney Int Suppl 2003: S119–S121CrossRefGoogle Scholar
  28. 28.
    Aparicio M, Combe C, Lafage MH, de P, V, Potaux L, Bouchet JL (1993) In advanced renal failure, dietary phosphorus restriction reverses hyperparathyroidism independent of changes in the levels of calcitriol. Nephron 63:122–123PubMedGoogle Scholar
  29. 29.
    Martinez I, Saracho R, Montenegro J, Llach F (1997) The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 29:496–502PubMedGoogle Scholar
  30. 30.
    Slatopolsky E, Caglar S, Pennell JP, Taggart DD, Canterbury JM, Reiss E, Bricker NS (1971) On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest 50:492–499PubMedGoogle Scholar
  31. 31.
    Nestel AW, Meyers AM, Paiker J, Rollin HB (1994) Effect of calcium supplement preparation containing small amounts of citrate on the absorption of aluminium in normal subjects and in renal failure patients. Nephron 68:197–201PubMedGoogle Scholar
  32. 32.
    Emmett M, Sirmon MD, Kirkpatrick WG, Nolan CR, Schmitt GW, Cleveland MB (1991) Calcium acetate control of serum phosphorus in hemodialysis patients. Am J Kidney Dis 17:544–550PubMedGoogle Scholar
  33. 33.
    Slatopolsky E, Weerts C, Lopez-Hilker S, Norwood K, Zink M, Windus D, Delmez J (1986) Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 315:157–161PubMedCrossRefGoogle Scholar
  34. 34.
    Drueke TB (2000) Renal osteodystrophy: management of hyperphosphataemia. Nephrol Dial Transplant 15(suppl 5):32–33PubMedCrossRefGoogle Scholar
  35. 35.
    Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478–1483PubMedCrossRefGoogle Scholar
  36. 36.
    Guerin AP, London GM, Marchais SJ, Metivier F (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014–1021PubMedCrossRefGoogle Scholar
  37. 37.
    Bleyer AJ, Burke SK, Dillon M, Garrett B, Kant KS, Lynch D, Rahman SN, Schoenfeld P, Teitelbaum I, Zeig S, Slatopolsky E (1999) A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Am J Kidney Dis 33:694–701PubMedGoogle Scholar
  38. 38.
    Slatopolsky EA, Burke SK, Dillon MA (1999) RenaGel, a nonabsorbed calcium-and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group. Kidney Int 55:299–307PubMedCrossRefGoogle Scholar
  39. 39.
    Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245–252PubMedCrossRefGoogle Scholar
  40. 40.
    Qunibi WY, Hootkins RE, McDowell LL, Meyer MS, Simon M, Garza RO, Pelham RW, Cleveland MV, Muenz LR, He DY, Nolan CR (2004) Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study). Kidney Int 65:1914–1926PubMedCrossRefGoogle Scholar
  41. 41.
    Hergesell O, Ritz E (2002) Phosphate binders in uraemia: pharmacodynamics, pharmacoeconomics, pharmacoethics. Nephrol Dial Transplant 17:14–17PubMedCrossRefGoogle Scholar
  42. 42.
    D’Haese PC, Spasovski GB, Sikole A, Hutchison A, Freemont TJ, Sulkova S, Swanepoel C, Pejanovic S, Djukanovic L, Balducci A, Coen G, Sulowicz W, Ferreira A, Torres A, Curic S, Popovic M, Dimkovic N, De Broe ME (2003) A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int Suppl S73–S78Google Scholar
  43. 43.
    Finn WF, Joy MS, Hladik G (2004) Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis. Clin Nephrol 62:193–201PubMedGoogle Scholar
  44. 44.
    Slatopolsky E, Finch J, Brown A (2003) New vitamin D analogs. Kidney Int Suppl 2003:S83–S87CrossRefGoogle Scholar
  45. 45.
    Malluche HH, Mawad H, Koszewski NJ (2002) Update on vitamin D and its newer analogues: actions and rationale for treatment in chronic renal failure. Kidney Int 62:367–374PubMedCrossRefGoogle Scholar
  46. 46.
    Sprague SM, Llach F, Amdahl M, Taccetta C, Batlle D (2003) Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int 63:1483–1490PubMedCrossRefGoogle Scholar
  47. 47.
    Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC (1993) Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366:575–580PubMedCrossRefGoogle Scholar
  48. 48.
    Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, Balandrin MF (1998) Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 95:4040–4045PubMedCrossRefGoogle Scholar
  49. 49.
    Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, Barri YM, Cohen RM, Coburn JW (2002) The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13:1017–1024PubMedGoogle Scholar
  50. 50.
    Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516–1525PubMedCrossRefGoogle Scholar
  51. 51.
    Cohen EP, Moulder JE (2001) Parathyroidectomy in chronic renal failure: has medical care reduced the need for surgery? Nephron 89:271–273PubMedCrossRefGoogle Scholar
  52. 52.
    Jorge Cannata-Andia JP-DER (2000) Management of the renal patient: experts’ recommendations and clinical algorithms on renal osteodystrophy and cardiovascular risk factors. Nephrol Dial Transplant 15:S1–S154CrossRefGoogle Scholar
  53. 53.
    Saha HH, Salmela KT, Ahonen PJ, Pietila KO, Morsky PJ, Mustonen JT, Lalla ML, Pasternack AI (1994) Sequential changes in vitamin D and calcium metabolism after successful renal transplantation. Scand J Urol Nephrol 28:21–27PubMedGoogle Scholar
  54. 54.
    Messa P, Sindici C, Cannella G, Miotti V, Risaliti A, Gropuzzo M, Di Loreto PL, Bresadola F, Mioni G (1998) Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int 54:1704–1713PubMedCrossRefGoogle Scholar
  55. 55.
    Heaf J, Tvedegaard E, Kanstrup IL, Fogh-Andersen N (2000) Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14:457–463PubMedCrossRefGoogle Scholar
  56. 56.
    Julian BA, Quarles LD, Niemann KM (1992) Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis 19:99–120PubMedGoogle Scholar
  57. 57.
    Torres A, Rodriguez AP, Concepcion MT, Garcia S, Rufino M, Martin B, Perez L, Machado M, de Bonis E, Losada M, Hernandez D, Lorenzo V (1998) Parathyroid function in long-term renal transplant patients: importance of pretransplant PTH concentrations. Nephrol Dial Transplant 13(suppl 3):94–97PubMedCrossRefGoogle Scholar
  58. 58.
    Caravaca F, Fernandez MA, Ruiz-Calero R, Cubero J, Aparicio A, Jimenez F, Garcia MC (1998) Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients. Nephrol Dial Transplant 13:2605–2611PubMedCrossRefGoogle Scholar
  59. 59.
    Koch Nogueira PC, David L, Cochat P (2000) Evolution of secondary hyperparathyroidism after renal transplantation. Pediatr Nephrol 14:342–346PubMedCrossRefGoogle Scholar
  60. 60.
    Parfitt AM (1997) The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 52:3–9PubMedGoogle Scholar
  61. 61.
    Bonarek H, Merville P, Bonarek M, Moreau K, Morel D, Aparicio M, Potaux L (1999) Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int 56:642–649PubMedCrossRefGoogle Scholar
  62. 62.
    Fernandez E, Fibla J, Betriu A, Piulats JM, Almirall J, Montoliu J (1997) Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol 8:1546–1552PubMedGoogle Scholar
  63. 63.
    Torres A, Machado M, Concepcion MT, Martin N, Lorenzo V, Hernandez D, Rodriguez AP, Rodriguez A, de Bonis E, Gonzalez-Posada JM, Hernandez A, Salido E (1996) Influence of vitamin D receptor genotype on bone mass changes after renal transplantation. Kidney Int 50:1726–1733PubMedGoogle Scholar
  64. 64.
    Lotscher M, Scarpetta Y, Levi M, Halaihel N, Wang H, Zajicek HK, Biber J, Murer H, Kaissling B (1999) Rapid downregulation of rat renal Na/P(i) cotransporter in response to parathyroid hormone involves microtubule rearrangement. J Clin Invest 104:483–494PubMedCrossRefGoogle Scholar
  65. 65.
    Pabico RC, McKenna BA (1988) Metabolic problems in renal transplant patients. Persistent hyperparathyroidism and hypophosphatemia: effects of intravenous calcium infusion. Transplant Proc 20:438–442PubMedGoogle Scholar
  66. 66.
    Steiner RW, Ziegler M, Halasz NA, Catherwood BD, Manolagas S, Deftos LJ (1993) Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients. Transplantation 56:843–846PubMedCrossRefGoogle Scholar
  67. 67.
    Ambuhl PM, Meier D, Wolf B, Dydak U, Boesiger P, Binswanger U (1999) Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis. Am J Kidney Dis 34:875–883PubMedGoogle Scholar
  68. 68.
    Ravid M, Robson M (1976) Proximal myopathy caused by iatrogenic phosphate depletion. JAMA 236:1380–1381PubMedCrossRefGoogle Scholar
  69. 69.
    Knochel JP (1992) Hypophosphatemia and rhabdomyolysis. Am J Med 92:455–457PubMedCrossRefGoogle Scholar
  70. 70.
    O’Connor LR, Wheeler WS, Bethune JE (1977) Effect of hypophosphatemia on myocardial performance in man. N Engl J Med 297:901–903PubMedCrossRefGoogle Scholar
  71. 71.
    Newman JH, Neff TA, Ziporin P (1977) Acute respiratory failure associated with hypophosphatemia. N Engl J Med 296:1101–1103PubMedCrossRefGoogle Scholar
  72. 72.
    Planas RF, McBrayer RH, Koen PA (1982) Effects of hypophosphatemia on pulmonary muscle performance. Adv Exp Med Biol 151:283–290PubMedGoogle Scholar
  73. 73.
    Klock JC, Williams HE, Mentzer WC (1974) Hemolytic anemia and somatic cell dysfunction in severe hypophosphatemia. Arch Intern Med 134:360–364PubMedCrossRefGoogle Scholar
  74. 74.
    Craddock PR, Yawata Y, VanSanten L, Gilberstadt S, Silvis S, Jacob HS (1974) Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med 290:1403–1407PubMedCrossRefGoogle Scholar
  75. 75.
    Subramanian R, Khardori R (2000) Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment. Medicine (Baltimore) 79:1–8PubMedCrossRefGoogle Scholar
  76. 76.
    Bellorin-Font E, Rojas E, Carlini RG, Suniaga O, Weisinger JR (2003) Bone remodeling after renal transplantation. Kidney Int Suppl 2003:S125–S128CrossRefGoogle Scholar
  77. 77.
    Almond MK, Kwan JT, Evans K, Cunningham J (1994) Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 66:52–57PubMedGoogle Scholar
  78. 78.
    Horber FF, Casez JP, Steiger U, Czerniak A, Montandon A, Jaeger P (1994) Changes in bone mass early after kidney transplantation. J Bone Miner Res 9:1–9PubMedCrossRefGoogle Scholar
  79. 79.
    Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD (1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544–550PubMedCrossRefGoogle Scholar
  80. 80.
    Pichette V, Bonnardeaux A, Prudhomme L, Gagne M, Cardinal J, Ouimet D (1996) Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 28:105–114PubMedGoogle Scholar
  81. 81.
    Grotz WH, Mundinger FA, Gugel B, Exner V, Kirste G, Schollmeyer PJ (1994) Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients. Transplantation 58:912–915PubMedCrossRefGoogle Scholar
  82. 82.
    Nisbeth U, Lindh E, Ljunghall S, Backman U, Fellstrom B (1999) Increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation 67:1218–1222PubMedCrossRefGoogle Scholar
  83. 83.
    Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM (1999) Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456–463PubMedCrossRefGoogle Scholar
  84. 84.
    Cruz EA, Lugon JR, Jorgetti V, Draibe SA, Carvalho AB (2004) Histologic evolution of bone disease 6 months after successful kidney transplantation. Am J Kidney Dis 44:747–756PubMedCrossRefGoogle Scholar
  85. 85.
    Felsenfeld AJ, Gutman RA, Drezner M, Llach F (1986) Hypophosphatemia in long-term renal transplant recipients: effects on bone histology and 1,25-dihydroxycholecalciferol. Miner Electrolyte Metab 12:333–341PubMedGoogle Scholar
  86. 86.
    Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH (2000) High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 11:1093–1099PubMedGoogle Scholar
  87. 87.
    Rojas E, Carlini RG, Clesca P, Arminio A, Suniaga O, De Elguezabal K, Weisinger JR, Hruska KA, Bellorin-Font E (2003) The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int 63:1915–1923PubMedCrossRefGoogle Scholar
  88. 88.
    Reinhardt W, Bartelworth H, Jockenhovel F, Schmidt-Gayk H, Witzke O, Wagner K, Heemann UW, Reinwein D, Philipp T, Mann K (1998) Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 13:436–442PubMedGoogle Scholar
  89. 89.
    Torres A, Lorenzo V, Salido E (2002) Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 13:551–558PubMedGoogle Scholar
  90. 90.
    Peppers MP, Geheb M, Desai T (1991) Endocrine crises. Hypophosphatemia and hyperphosphatemia. Crit Care Clin 7:201–214PubMedGoogle Scholar
  91. 91.
    Lentz RD, Brown DM, Kjellstrand CM (1978) Treatment of severe hypophosphatemia. Ann Intern Med 89:941–944PubMedGoogle Scholar
  92. 92.
    Niederle B (2000) Sekundärer Hyperparathyreoidismus: Operative Therapie. In: Siewert JR, Harder F, Rothmund M (eds) Praxis der Viszeralchirurgie. Endokrine Chirurgie. Springer, Berlin, Heidelberg, New York, pp 309–315Google Scholar
  93. 93.
    Akerstrom G, Malmaeus J, Bergstrom R (1984) Surgical anatomy of human parathyroid glands. Surgery 95:14–21PubMedGoogle Scholar
  94. 94.
    Sitges-Serra A, Caralps-Riera A (1987) Hyperparathyroidism associated with renal disease. Pathogenesis, natural history, and surgical treatment. Surg Clin North Am 67:359–377PubMedGoogle Scholar
  95. 95.
    Tominaga Y, Numano M, Tanaka Y, et al (1997) Surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13:87–96PubMedCrossRefGoogle Scholar
  96. 96.
    Numano M, Tominaga Y, Uchida K, et al (1998) Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism. World J Surg 22:1098–1102; discussion 1103PubMedCrossRefGoogle Scholar
  97. 97.
    Rothmund M, Wagner PK (1983) Total parathyroidectomy and autotransplantation of parathyroid tissue for renal hyperparathyroidism. A one-to six-year follow-up. Ann Surg 197:7–16PubMedGoogle Scholar
  98. 98.
    Akerstrom G, Rudberg C, Grimelius L, Rastad J (1988) Recurrent hyperparathyroidism due to peroperative seeding of neoplastic or hyperplastic parathyroid tissue. Case report. Acta Chir Scand 154:549–552PubMedGoogle Scholar
  99. 99.
    Wells SA Jr, Gunnells JC, Shelburne JD, et al (1975) Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 78:34–44PubMedGoogle Scholar
  100. 100.
    Rothmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 15:745–750PubMedCrossRefGoogle Scholar
  101. 101.
    Wagner PK, Eckhardt J, Rothmund M (1991) [Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation in secondary hyperparathyroidism. A randomized study]. Chirurg 62:189–194PubMedGoogle Scholar
  102. 102.
    Kinnaert P, Salmon I, Decoster-Gervy C, et al (1993) Total parathyroidectomy and presternal subcutaneous implantation of parathyroid tissue for renal hyperparathyroidism. Surg Gynecol Obstet 176:135–138PubMedGoogle Scholar
  103. 103.
    Skinner KA, Zuckerbraun L (1996) Recurrent secondary hyperparathyroidism. An argument for total parathyroidectomy. Arch Surg 131:724–727PubMedGoogle Scholar
  104. 104.
    Jansson S, Tisell LE (1987) Autotransplantation of diseased parathyroid glands into subcutaneous abdominal adipose tissue. Surgery 101:549–556PubMedGoogle Scholar
  105. 105.
    Chou FF, Chan HM, Huang TJ, et al (1998) Autotransplantation of parathyroid glands into subcutaneous forearm tissue for renal hyperparathyroidism. Surgery 124:1–5PubMedGoogle Scholar
  106. 106.
    Wells SA Jr, Ross AJ 3rd, Dale JK, Gray RS (1979) Transplantation of the parathyroid glands: current status. Surg Clin North Am 59:167–177PubMedGoogle Scholar
  107. 107.
    D’Avanzo A, Parangi S, Morita E, et al (2000) Hyperparathyroidism after thyroid surgery and autotransplantation of histologically normal parathyroid glands. J Am Coll Surg 190:546–552PubMedCrossRefGoogle Scholar
  108. 108.
    Rothmund M (1986) Surgical treatment of secondary hyperparathyroidism: indication, operative management and results. Karger, BaselGoogle Scholar
  109. 109.
    Edis AJ, Levitt MD (1987) Supernumerary parathyroid glands: implications for the surgical treatment of secondary hyperparathyroidism. World J Surg 11:398–401PubMedCrossRefGoogle Scholar
  110. 110.
    Donckier V, Decoster-Gervy C, Kinnaert P (1997) Long-term results after surgical treatment of renal hyperparathyroidism when fewer than four glands are identified at operation. J Am Coll Surg 184:70–74PubMedGoogle Scholar
  111. 111.
    Freeman JB, Sherman BM, Mason EE (1976) Transcervical thymectomy: an integral part of neck exploration for hyperparathyroidism. Arch Surg 111:359–364PubMedGoogle Scholar
  112. 112.
    Dotzenrath C, Cupisti K, Goretzki E, et al (2003) Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg 387:348–354PubMedGoogle Scholar
  113. 113.
    Proye C, Carnaille B, Sautier M (1990) [Hyperparathyroidism in patients with chronic renal failure: subtotal parathyroidectomy or total parathyroidectomy with autotransplantation? Experience with 121 cases]. J Chir (Paris) 127:136–140Google Scholar
  114. 114.
    Malmaeus J, Akerstrom G, Johansson H, et al (1982) Parathyroid surgery in chronic renal insufficiency. Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation to the forearm. Acta Chir Scand 148:229–238PubMedGoogle Scholar
  115. 115.
    Ahlers J, Rothmund M (1980) [Cervical thymectomy as an expanded surgical method in primary and secondary hyperparathyroidism]. Chirurg 51:629–633PubMedGoogle Scholar
  116. 116.
    Hibi Y, Tominaga Y, Sato T, et al (2002) Reoperation for renal hyperparathyroidism. World J Surg 26:1301–1307PubMedCrossRefGoogle Scholar
  117. 117.
    Dotzenrath C, Goretzki PE, Roher HD (1996) [Results of surgical therapy in renal hyperparathyroidism. Follow-up of 143 patients]. Langenbecks Arch Chir 381:46–50PubMedCrossRefGoogle Scholar
  118. 118.
    Maier GW, Kreis ME, Renn W, et al (1998) Parathyroid hormone after adenectomy for primary hyperparathyroidism. A study of peptide hormone elimination kinetics in humans. J Clin Endocrinol Metab 83:3852–3856PubMedCrossRefGoogle Scholar
  119. 119.
    Mandell DL, Genden EM, Mechanick JI, et al (2001) The influence of intraoperative parathyroid hormone monitoring on the surgical management of hyperparathyroidism. Arch Otolaryngol Head Neck Surg 127:821–827PubMedGoogle Scholar
  120. 120.
    Maweja S, Sebag F, Hubbard J, et al (2004) Immediate and medium-term results of intraoperative parathyroid hormone monitoring during video-assisted parathyroidectomy. Arch Surg 139:1301–1303PubMedCrossRefGoogle Scholar
  121. 121.
    Chapuis Y, Fulla Y, Bonnichon P, et al (1996) Values of ultrasonography, sestamibi scintigraphy, and intraoperative measurement of 1-84 PTH for unilateral neck exploration of primary hyperparathyroidism. World J Surg 20:835–839; discussion 839–840PubMedCrossRefGoogle Scholar
  122. 122.
    Westerdahl J, Lindblom P, Bergenfelz A (2002) Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg 137:186–190PubMedCrossRefGoogle Scholar
  123. 123.
    Beck TM, Huber PR, Oertli D (2003) Intraoperative parathormone measurement in patients with primary hyperparathyroidism: a prospective clinical study. Swiss Med Wkly 133:206–209PubMedGoogle Scholar
  124. 124.
    Clary BM, Garner SC, Leight GS Jr (1997) Intraoperative parathyroid hormone monitoring during parathyroidectomy for secondary hyperparathyroidism. Surgery 122:1034–1038; discussion 1038–1039PubMedCrossRefGoogle Scholar
  125. 125.
    Chou FF, Lee CH, Chen JB, et al (2002) Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism. Arch Surg 137:341–344PubMedCrossRefGoogle Scholar
  126. 126.
    Seehofer D, Rayes N, Ulrich F, et al (2001) Intraoperative measurement of intact parathyroid hormone in renal hyperparathyroidism by an inexpensive routine assay. Langenbecks Arch Surg 386:440–443PubMedCrossRefGoogle Scholar
  127. 127.
    Niederle B, Roka R, Brennan MF (1982) The transplantation of parathyroid tissue in man: development, indications, technique, and results. Endocr Rev 3:245–279PubMedCrossRefGoogle Scholar
  128. 128.
    Neyer U, Hoerandner H, Haid A, et al (2002) Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection. Nephrol Dial Transplant 17:625–629PubMedCrossRefGoogle Scholar
  129. 129.
    Brunt LM, Wells SA Jr (1983) Surgical treatment of secondary hyperparathyroidism. Ann Chir Gynaecol 72:139–145PubMedGoogle Scholar
  130. 130.
    Welsh CL, Taylor GW, Cattell WR, Baker LR (1984) Parathyroid surgery in chronic renal failure: subtotal parathyroidectomy or autotransplantation? Br J Surg 71:591–592PubMedGoogle Scholar
  131. 131.
    Takagi H, Tominaga Y, Uchida K, et al (1984) Subtotal versus total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann Surg 200:18–23PubMedCrossRefGoogle Scholar
  132. 132.
    Patow CA, Norton JA, Brennan MF (1986) Vocal cord paralysis and reoperative parathyroidectomy. A prospective study. Ann Surg 203:282–285PubMedCrossRefGoogle Scholar
  133. 133.
    Gagne ER, Urena P, Leite-Silva S, et al (1992) Short-and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 3:1008–1017PubMedGoogle Scholar
  134. 134.
    Alexander PT, Schuman ES, Vetto RM, et al (1988) Repeat parathyroid operation associated with renal disease. Am J Surg 155:686–689PubMedCrossRefGoogle Scholar
  135. 135.
    Kaye M, D’Amour P, Henderson J (1989) Elective total parathyroidectomy without autotransplant in end-stage renal disease. Kidney Int 35:1390–1399PubMedGoogle Scholar
  136. 136.
    Hampl H, Steinmuller T, Stabell U, et al (1991) Recurrent hyperparathyroidism after total parathyroidectomy and autotransplantation in patients with long-term hemodialysis. Miner Electrolyte Metab 17:256–260PubMedGoogle Scholar
  137. 137.
    Frei U, Klempa I, Schneider M, et al (1981) Tumour-like growth of parathyroid autografts in uraemic patients. Proc Eur Dial Transplant Assoc 18:548–555PubMedGoogle Scholar
  138. 138.
    Korzets Z, Magen H, Kraus L, Bernheim J (1987) Total parathyroidectomy with autotransplantation in haemodialysed patients with secondary hyperparathyroidism: should it be abandoned? Nephrol Dial Transplant 2:341–346PubMedGoogle Scholar
  139. 139.
    Ellis HA (1988) Fate of long-term parathyroid autografts in patients with chronic renal failure treated by parathyroidectomy: a histopathological study of autografts, parathyroid glands and bone. Histopathology 13:289–309PubMedGoogle Scholar
  140. 140.
    Max MH, Flint LM, Richardson JD, et al (1981) Total parathyroidectomy and parathyroid autotransplantation in patients with chronic renal failure. Surg Gynecol Obstet 153:177–180PubMedGoogle Scholar
  141. 141.
    Mozes MF, Soper WD, Jonasson O, Lang GR (1980) Total parathyroidectomy and autotransplantation in secondary hyperparathyroidism. Arch Surg 115:378–385PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Authors and Affiliations

  • Ulrich Güller
    • 1
  • Michael Mayr
    • 2
  1. 1.Department of Surgery, Divisions of General Surgery and Surgical ResearchUniversity of BaselBaselSwitzerland
  2. 2.Division of Transplantation Immunology and Nephrology, Department of Internal MedicineUniversity of BaselBaselSwitzerland

Personalised recommendations